Patent lanscape analisys of mRNA Covid-19 vaccine technology: examining the role of biotech companies, public research and universities
Langue
EN
Chapitre d'ouvrage
Ce document a été publié dans
HANDBOOK OF INNOVATION AND INTELLECTUAL PROPERTY RIGHTS: evolving. 2024-09-12p. 417-439
Edward Elgar Publishing
Résumé en anglais
This chapter analyzes the patent landscape of the mRNA Covid-19 vaccine technology. It shows the growth of patents in this field, the share of patents held by various biotechnological companies and the important role of ...Lire la suite >
This chapter analyzes the patent landscape of the mRNA Covid-19 vaccine technology. It shows the growth of patents in this field, the share of patents held by various biotechnological companies and the important role of universities and research centers. This chapter also provides initial evidence regarding the growth of patent litigation cases and infringement actions caused by the start of large-scale production. The chapter discusses two critical issues. (1) The role of university patents and the link between scientific research in universities and public research centers and the commercialization and development of the final products. (2) The fragmentation of intellectual property and how, in these circumstances, it could increase transaction costs and barriers to entry.< Réduire
Mots clés en anglais
Covid-19 vaccines
Innovation
Intellectual property rights
Patents
Unités de recherche